Quotes 5-day view Delayed Nyse
10/19/2020
10/20/2020
10/21/2020
10/22/2020
10/23/2020
Date
47.9(c)
47.71(c)
47.83(c)
48.77(c)
49.34(c)
Last
1 791 457
1 678 557
1 294 435
1 396 519
1 284 651
Volume
-1.82% -0.40% +0.25% +1.97% +1.17% Change
Sales 2021
159 B - -
Net income 2021
1 271 M - -
Net Debt 2021
2 865 M - -
P/E ratio 2021
12,0x
Yield 2021
4,01%
Sales 2022
166 B - -
Net income 2022
1 358 M - -
Net Debt 2022
1 709 M - -
P/E ratio 2022
10,9x
Yield 2022
4,11%
Capitalization
14 476 M 14 476 M -
EV / Sales 2021
0,11x
EV / Sales 2022
0,10x
Nbr of Employees
48 000
Free-Float
89,4%
Cardinal Health is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (88.6%);
- distribution of medical, surgical and laboratory products (11.4%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic...
Notations Surperformance© of Cardinal Health, Inc.
Trading Rating : Investor Rating :
All news about CARDINAL HEALTH, INC.
News in other languages on CARDINAL HEALTH, INC.
Analyst Recommendations on CARDINAL HEALTH, INC.
J&J to contribute up to $5 billion to potential U.S. opioid settlement
Chart CARDINAL HEALTH, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CARDINAL HEALTH, INC.
Short Term Mid-Term Long Term Trends Bullish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
19
Average target price
59,20 $
Last Close Price
49,34 $
Spread / Highest target
29,7%
Spread / Average Target
20,0%
Spread / Lowest Target
1,34%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
